EQUASENS (EQS.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:EQS • FR0012882389

38.6 EUR
-1.2 (-3.02%)
Last: Feb 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

EQS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 12 industry peers in the Health Care Technology industry. EQS has an excellent profitability rating, but there are some minor concerns on its financial health. EQS scores decently on growth, while it is valued quite cheap. This could make an interesting combination. EQS also has an excellent dividend rating. These ratings would make EQS suitable for value and dividend investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year EQS was profitable.
  • EQS had a positive operating cash flow in the past year.
  • Each year in the past 5 years EQS has been profitable.
  • EQS had a positive operating cash flow in each of the past 5 years.
EQS.PA Yearly Net Income VS EBIT VS OCF VS FCFEQS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

1.2 Ratios

  • EQS has a Return On Assets of 8.82%. This is in the better half of the industry: EQS outperforms 66.67% of its industry peers.
  • EQS has a Return On Equity of 15.77%. This is amongst the best in the industry. EQS outperforms 91.67% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 12.84%, EQS belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for EQS is significantly above the industry average of 8.64%.
Industry RankSector Rank
ROA 8.82%
ROE 15.77%
ROIC 12.84%
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
EQS.PA Yearly ROA, ROE, ROICEQS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • With a decent Profit Margin value of 16.13%, EQS is doing good in the industry, outperforming 75.00% of the companies in the same industry.
  • In the last couple of years the Profit Margin of EQS has remained more or less at the same level.
  • EQS's Operating Margin of 20.02% is fine compared to the rest of the industry. EQS outperforms 75.00% of its industry peers.
  • In the last couple of years the Operating Margin of EQS has declined.
  • EQS has a Gross Margin (68.81%) which is in line with its industry peers.
  • EQS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.02%
PM (TTM) 16.13%
GM 68.81%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
EQS.PA Yearly Profit, Operating, Gross MarginsEQS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so EQS is creating value.
  • Compared to 1 year ago, EQS has about the same amount of shares outstanding.
  • EQS has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for EQS has been reduced compared to a year ago.
EQS.PA Yearly Shares OutstandingEQS.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
EQS.PA Yearly Total Debt VS Total AssetsEQS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • An Altman-Z score of 3.76 indicates that EQS is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of EQS (3.76) is better than 66.67% of its industry peers.
  • EQS has a debt to FCF ratio of 0.98. This is a very positive value and a sign of high solvency as it would only need 0.98 years to pay back of all of its debts.
  • EQS has a better Debt to FCF ratio (0.98) than 66.67% of its industry peers.
  • A Debt/Equity ratio of 0.09 indicates that EQS is not too dependend on debt financing.
  • The Debt to Equity ratio of EQS (0.09) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.98
Altman-Z 3.76
ROIC/WACC1.64
WACC7.84%
EQS.PA Yearly LT Debt VS Equity VS FCFEQS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 1.29 indicates that EQS should not have too much problems paying its short term obligations.
  • EQS has a Current ratio (1.29) which is in line with its industry peers.
  • EQS has a Quick Ratio of 1.20. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.20, EQS is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.2
EQS.PA Yearly Current Assets VS Current LiabilitesEQS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • EQS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.90%.
  • The Earnings Per Share has been growing slightly by 5.12% on average over the past years.
  • Looking at the last year, EQS shows a small growth in Revenue. The Revenue has grown by 4.45% in the last year.
  • Measured over the past years, EQS shows a small growth in Revenue. The Revenue has been growing by 6.45% on average per year.
EPS 1Y (TTM)-13.9%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%

3.2 Future

  • EQS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.19% yearly.
  • The Revenue is expected to grow by 7.74% on average over the next years.
EPS Next Y11.67%
EPS Next 2Y15.06%
EPS Next 3Y14.19%
EPS Next 5YN/A
Revenue Next Year9.72%
Revenue Next 2Y9.5%
Revenue Next 3Y5.96%
Revenue Next 5Y7.74%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EQS.PA Yearly Revenue VS EstimatesEQS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
EQS.PA Yearly EPS VS EstimatesEQS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 16.08, EQS is valued correctly.
  • EQS's Price/Earnings ratio is rather cheap when compared to the industry. EQS is cheaper than 83.33% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of EQS to the average of the S&P500 Index (27.92), we can say EQS is valued slightly cheaper.
  • Based on the Price/Forward Earnings ratio of 12.72, the valuation of EQS can be described as correct.
  • 83.33% of the companies in the same industry are more expensive than EQS, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of EQS to the average of the S&P500 Index (27.78), we can say EQS is valued rather cheaply.
Industry RankSector Rank
PE 16.08
Fwd PE 12.72
EQS.PA Price Earnings VS Forward Price EarningsEQS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • EQS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. EQS is cheaper than 83.33% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, EQS is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 15.7
EV/EBITDA 7.73
EQS.PA Per share dataEQS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of EQS may justify a higher PE ratio.
  • A more expensive valuation may be justified as EQS's earnings are expected to grow with 14.19% in the coming years.
PEG (NY)1.38
PEG (5Y)3.14
EPS Next 2Y15.06%
EPS Next 3Y14.19%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. Dividend

5.1 Amount

  • EQS has a Yearly Dividend Yield of 3.14%. Purely for dividend investing, there may be better candidates out there.
  • EQS's Dividend Yield is a higher than the industry average which is at 2.11.
  • Compared to an average S&P500 Dividend Yield of 1.81, EQS pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.14%

5.2 History

  • The dividend of EQS is nicely growing with an annual growth rate of 8.00%!
Dividend Growth(5Y)8%
Div Incr Years1
Div Non Decr Years2
EQS.PA Yearly Dividends per shareEQS.PA Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • 51.82% of the earnings are spent on dividend by EQS. This is a bit on the high side, but may be sustainable.
  • EQS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP51.82%
EPS Next 2Y15.06%
EPS Next 3Y14.19%
EQS.PA Yearly Income VS Free CF VS DividendEQS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
EQS.PA Dividend Payout.EQS.PA Dividend Payout, showing the Payout Ratio.EQS.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

EQUASENS

EPA:EQS (2/6/2026, 7:00:00 PM)

38.6

-1.2 (-3.02%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-05
Earnings (Next)04-29
Inst Owners11.7%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap585.56M
Revenue(TTM)224.73M
Net Income(TTM)36.26M
Analysts83.33
Price Target54.06 (40.05%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.14%
Yearly Dividend1.25
Dividend Growth(5Y)8%
DP51.82%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.25%
PT rev (3m)8.16%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.17%
EPS NY rev (3m)-1.17%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 16.08
Fwd PE 12.72
P/S 2.61
P/FCF 15.7
P/OCF 12
P/B 2.55
P/tB 7.33
EV/EBITDA 7.73
EPS(TTM)2.4
EY6.22%
EPS(NY)3.04
Fwd EY7.86%
FCF(TTM)2.46
FCFY6.37%
OCF(TTM)3.22
OCFY8.33%
SpS14.81
BVpS15.16
TBVpS5.27
PEG (NY)1.38
PEG (5Y)3.14
Graham Number28.61
Profitability
Industry RankSector Rank
ROA 8.82%
ROE 15.77%
ROCE 15.76%
ROIC 12.84%
ROICexc 18.12%
ROICexgc 70.2%
OM 20.02%
PM (TTM) 16.13%
GM 68.81%
FCFM 16.6%
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
ROICexc(3y)19.08%
ROICexc(5y)21.2%
ROICexgc(3y)48.92%
ROICexgc(5y)61.81%
ROCE(3y)18.64%
ROCE(5y)19.75%
ROICexgc growth 3Y-28.73%
ROICexgc growth 5Y-12.2%
ROICexc growth 3Y-17.5%
ROICexc growth 5Y-11.29%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
F-Score7
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.98
Debt/EBITDA 0.32
Cap/Depr 70.06%
Cap/Sales 5.11%
Interest Coverage 250
Cash Conversion 79.48%
Profit Quality 102.89%
Current Ratio 1.29
Quick Ratio 1.2
Altman-Z 3.76
F-Score7
WACC7.84%
ROIC/WACC1.64
Cap/Depr(3y)96.13%
Cap/Depr(5y)118.08%
Cap/Sales(3y)6.18%
Cap/Sales(5y)7.08%
Profit Quality(3y)94.47%
Profit Quality(5y)93.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.9%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
EPS Next Y11.67%
EPS Next 2Y15.06%
EPS Next 3Y14.19%
EPS Next 5YN/A
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%
Revenue Next Year9.72%
Revenue Next 2Y9.5%
Revenue Next 3Y5.96%
Revenue Next 5Y7.74%
EBIT growth 1Y-7%
EBIT growth 3Y-4.55%
EBIT growth 5Y1.4%
EBIT Next Year55.72%
EBIT Next 3Y25.38%
EBIT Next 5YN/A
FCF growth 1Y-36.45%
FCF growth 3Y-1.08%
FCF growth 5Y8.7%
OCF growth 1Y-30.97%
OCF growth 3Y0.02%
OCF growth 5Y3.18%

EQUASENS / EQS.PA FAQ

What is the ChartMill fundamental rating of EQUASENS (EQS.PA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to EQS.PA.


What is the valuation status of EQUASENS (EQS.PA) stock?

ChartMill assigns a valuation rating of 7 / 10 to EQUASENS (EQS.PA). This can be considered as Undervalued.


What is the profitability of EQS stock?

EQUASENS (EQS.PA) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for EQS stock?

The Price/Earnings (PE) ratio for EQUASENS (EQS.PA) is 16.08 and the Price/Book (PB) ratio is 2.55.


What is the expected EPS growth for EQUASENS (EQS.PA) stock?

The Earnings per Share (EPS) of EQUASENS (EQS.PA) is expected to grow by 11.67% in the next year.